PQRI 2010 Enrollment Deadline Extended to March 5 2011
Thursday, February 10th, 2011In the 2010 PQRI program, new measures groups for coronary artery disease (CAD) and heart failure (HF) are available for reporting and require physicians to report on only 30 patients instead of 80 percent of eligible patients to qualify for a 2 percent bonus. The patients also no longer need to be consecutive. In addition to the measures groups, there are five new individual measures for 2010 that can be reported through a registry:
- CAD: Symptom and Activity Assessment
- CAD: Drug Therapy for Lowering LDL Cholesterol
- HF: Left Ventricular Function (LVF) Assessment
- HF: Patient Education
- HF: Warfarin Therapy for Patients with Atrial Fibrillation
Most cardiologists that participated in PQRI over the past two years have participated using the claims-based process, but that option has been eliminated for most of the measures that have been developed by ACC. Physicians who wish to participate using ACC-developed measures now must report through a registry. ACC’s PINNACLE RegistryTM is a qualified PQRI registry. In addition, the ACC has partnered with CECity to offer ACC members an easy online tool, PQRIwizard SM, to participate in the 2010 PQRI measures groups. CECity is also an online, subscription-based, qualified PQRI registry.
Cardiologists who wish to continue participation in PQRI via claims-based submission should carefully review the list of eligible measures to determine which measures they will report. Although there is only one ACC-supported option (Measure 6: Antiplatelet therapy prescribed for CAD patients), there are measures that were not developed by ACC that cardiologists are eligible to report.
from http://www.cardiosource.org/
- CAD: Symptom and Activity Assessment
- CAD: Drug Therapy for Lowering LDL Cholesterol
- HF: Left Ventricular Function (LVF) Assessment
- HF: Patient Education
- HF: Warfarin Therapy for Patients with Atrial Fibrillation
Most cardiologists that participated in PQRI over the past two years have participated using the claims-based process, but that option has been eliminated for most of the measures that have been developed by ACC. Physicians who wish to participate using ACC-developed measures now must report through a registry. ACC’s PINNACLE RegistryTM is a qualified PQRI registry. In addition, the ACC has partnered with CECity to offer ACC members an easy online tool, PQRIwizard SM, to participate in the 2010 PQRI measures groups. CECity is also an online, subscription-based, qualified PQRI registry.
Cardiologists who wish to continue participation in PQRI via claims-based submission should carefully review the list of eligible measures to determine which measures they will report. Although there is only one ACC-supported option (Measure 6: Antiplatelet therapy prescribed for CAD patients), there are measures that were not developed by ACC that cardiologists are eligible to report.
